GlaxoSmithKline's total assets for Q2 2026 were £61.37B, a decrease of -25.98% from the previous quarter. MX:GSKN total liabilities were £44.29B for the fiscal quarter, a -26.09% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.